On May 31 and June 17, MannKind announced that it had completed its new phase 3 clinical studies of Afrezza for people with type 1 and 2 diabetes. As a reminder, Afrezza...

(S)he said what!?

On October 14, Cellnovo announced the start of a usability study of its mobile-enabled insulin pump in the UK. The trial will essentially study how patients like using...

In a live online chat on March 31, highly-regarded FDA Director Dr. Courtney Lias and patient advocate Bennet Dunlap, founder of Strip Safely discussed the new blood...

(S)he said what!?

In May 2013, Jawbone announced the acquisition of BodyMedia and the launch of a new app platform for its UP health wristband , which tracks movement and sleep and syncs...

LifeScan’s OneTouch VerioSync meter – the magic of wireless blood glucose data to your iPhone/iPod/iPad.

On November 25, the FDA announced the removal of the major restrictions on the prescription and use of GlaxoSmithKline’s Avandia (rosiglitazone) for type 2 diabetes...

Inspiring non-profit Insulindependence recently launched a member search feature that allows users to search for other people with diabetes in their area with similar...

On April 16, Vivus announced that the FDA approved a change to the distribution of Qsymia . Qsymia is a weight loss and weight management drug that is designed to be...

The challenges and triumphs of providing high quality diabetes care in low-income communities.

On August 23, the American Association of Clinical Endocrinologists (AACE) announced that it will hold a consensus conference on obesity called “Building an Evidence...

On January 27, Asante and Tidepool announced an insulin pump data downloading partnership for the Snap insulin pump . The agreement marks the first diabetes device...

StripSafely is a new advocacy campaign that encourages people with diabetes and caregivers to write Congress and push the FDA on an important issue: glucose test strip...

On October 3, Orexigen announced that it submitted Contrave (naltrexone/bupropion) to the European Medicine Agency for weight loss management. Assuming a successful...

On March 18, NeuroMetrix launched the second-generation version of its Sensus pain management device, The Sensus is designed to relieve the pain and numbness often...

A whole new approach to treating type 2 diabetes at diagnosis, a new type of metformin, and the benefit of adding a GLP-1 agonist to insulin.

On September 9, the Diabetes Technology Society (DTS) will hold a meeting in Bethesda, Maryland, to discuss higher standards for blood glucose monitors and strips, with...

The New York Times publishes a critical front page piece on type 1 diabetes costs and devices - what we wish they would have written.

On December 27, Takeda announced that it would stop development of TAK-875 (fasiglifam) due to liver safety concerns – this was one of the most unfortunate announcements...